Stem cells, explained in plain language

A stem cell is a cell that has not yet settled into a fixed job. Two properties define it. It can divide to produce more cells like itself, and under the right biological conditions it can develop into a more specialised cell type. Scientists call these self-renewal and differentiation.

Those two words describe a family, not a single product. The blood-forming stem cells used in bone marrow transplantation are a different family from the mesenchymal stromal cells used in regenerative medicine. Our programme works with MSCs, and specifically with Wharton's jelly MSCs, and the guides on this page explain what that means for your treatment.

MSCs are studied less for what they become and more for what they communicate. They release cytokines, growth factors and small membrane-bound particles that influence the cells around them. That short-range conversation is called paracrine and cytokine signalling, and it is the biological rationale behind most regenerative medicine research.

Researchers follow several strands of that conversation: helping influence how the immune system and inflammatory response behave, known as immunomodulation; modulating the inflammatory pathways involved in chronic conditions; supporting the growth of small blood vessels, called angiogenic signalling; interacting with the extracellular matrix that surrounds cells; supporting the tissue in its own local repair processes; and, in nerve-related research, the support of nerve cells known as neurotrophic signalling.

This is why the accurate description of MSC therapy is a treatment aimed at the environment around the tissue. The research describes cells that signal and interact, not cells that travel to an injury and become replacement tissue.

Every plan begins with records rather than a package. Our medical team reviews your diagnosis, imaging, medications and goals, then explains which options may fit your case and which would not. Where we do not believe treatment is appropriate, we say so and explain why.

Regenerative medicine treatments are planned individually. Responses vary and no clinical outcome can be guaranteed. Suitability is confirmed only after medical review, and treatment is planned alongside the care you already receive at home.